Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of XRCC4 in carcinogenesis and anticancer drug discovery.

Recent patents on anti-cancer drug discovery - 1 Nov 2008

Wu Cheng-Nan, Liang Shiu-Yun, Tsai Chia-Wen, Bau Da-Tian

Abstract excerpt

In the past decades, the incidence of cancer keeps its rapid increasing step all over the world and cancer is always an important threat to public health. It is believed that cancer is resulted from a series of genetic alterations leading to progressive disorder of the normal mechanisms controlling cell proliferation, differentiation, death, and/or genomic stability. The response of the cell to genetic injury and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Clinical Trials as Topic
Share to DNA Repair

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Delivery Systems

Share to Drug Discovery

Share to Genetic Therapy

Share to Genomics

Share to Pharmacogenetics

Source

Identifiers

PMID: 18991789
DOI: 10.2174/157489208786242304

Genes

XRCC4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of XRCC4 in carcinogenesis and anticancer drug discovery.PMID 18991789Read ↗

The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and CancerSemantic proximity Read ↗

An updated meta-analysis of XRCC4 polymorphisms and cancer risk based on 31 case-control studies.Semantic proximity Read ↗

X-ray cross-complementing family: the bridge linking DNA damage repair and cancerSemantic proximity Read ↗

Choices have consequences: the nexus between DNA repair pathways and genomic instability in cancerSemantic proximity Read ↗

Pathways of DNA double-strand break repair and their impact on the prevention and formation of chromosomal aberrationsSemantic proximity Read ↗

Targeting DNA Double-Strand Break (DSB) Repair to Counteract Tumor Radio-resistanceSemantic proximity Read ↗

CRL4ADTL degrades DNA-PKcs to modulate NHEJ repair and induce genomic instability and subsequent malignant transformationSemantic proximity Read ↗

A Comprehensive Analysis of Alterations in DNA Damage Repair Pathways Reveals a Potential Way to Enhance the Radio-Sensitivity of Esophageal Squamous Cell CancerSemantic proximity Read ↗

New Discoveries on Protein Recruitment and Regulation during the Early Stages of the DNA Damage Response PathwaysSemantic proximity Read ↗

Exploring homologous recombination repair and base excision repair pathway genes for possible diagnostic markers in hematologic malignancies.Semantic proximity Read ↗

Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer’s Achilles’ HeelSemantic proximity Read ↗

XPA: A key scaffold for human nucleotide excision repair.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.